MAP4K4 Inhibitors
Loading...
Embargo End Date
ICR Authors
Authors
Newton, G
Schneider, M
Schneider, M
Document Type
Patent
Date
2019-04-18
Date Accepted
Abstract
This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, for example in a method of treatment. There are also provided processes for producing compounds of the present invention and method of their use. In particular, the present invention relates to compounds of formula (I).
Citation
2019
DOI
Rights
Source Title
Publisher
ISSN
eISSN
Collections
Research Team
Medicinal Chemistry 3